High-dose intravenous glucocorticoid therapy for graves' ophthalmopathy: Where are we now?

Thyroid

Volumn 22, Issue 1, 2012, Pages 1-2

  Bahn, Rebecca ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; GLUCOCORTICOID; GLUCOSE; LIVER ENZYME; METHYLPREDNISOLONE; PREDNISONE;

ACUTE LIVER FAILURE; BLOOD PRESSURE MONITORING; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EDITORIAL; ENDOCRINE OPHTHALMOPATHY; GLAUCOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIVER FUNCTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; ULTRASOUND; VIRUS HEPATITIS;

FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; METHYLPREDNISOLONE;

EID: 84855464445     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.2201.ed     Document Type: Editorial

References (8)

1. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall- Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18:333-346. (Pubitemid 351415802)
2. Zang S, Ponto KA, Kahaly GJ 2011 Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab 96:320-332.
3. Weissel M, Hauff W 2000 Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 10:521. (Pubitemid 30437157)
4. Marino M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marocci C 2004 Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid 14:403-406. (Pubitemid 38756663)
5. Salvi M, Vannucchi G, Sbrozzi F, Del Castello AB, Carnevali A, Fargion S, Beck-Peccoz P 2004 Onset of autoimmune hepatitis during intravenous steroid therapy for thyroidassociated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid 14:631-634. (Pubitemid 39097088)
6. Wichary H, Gasińska T 2011 Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy. Thyroid 22: 64-69.
7. Le Moli R, Baldeschi L, Saeed P, Regensburg N, Mourits MP, Wiersinga WM 2007 Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 17:357-362. (Pubitemid 46776141)
8. Hart RH, Kendall-Taylor P, Crombie A, Perros P 2005 Early response to intravenous glucocorticoids for severe thyroidassociated ophthalmopathy predicts treatment outcome. J Ocul Pharmacol Ther 21:328-336. (Pubitemid 41192904)